Furthermore, it reduced E2F-1 cell cycle-related proteins while increasing Wnt/-catenin pathways. GSK-3 activation reduced the expression of c-MYC, and cyclin D1, which aided anti-proliferative activity [156]. These fucoidans were found to have anticancer activity in HeLa, A549, and HepG2 ...